Table 2 Characteristics and knowledge of VHVs in six provinces of Laos, 2007
Non pilot area n = 18 (%) | Pilot area n = 18 (%) | p | Total n = 36 | |
|---|---|---|---|---|
Sex (female) | 0 (0) | 3 (16.67) | 0.07 | 3 (8.33) |
Age (years)* | 34.66 (28.71-40.61) | 38.22 (33.75-42.68) | 0.3 | 36.44 (32.86-40.02) |
Training on RDT* (days) | 2.61 (1.99-3.22) | 2.72 (2.07-2.92) | 0.7 | 2.55 (2.19-2.91) |
Number of training | 1.55 (1.20-1.90) | 3.33 (2.15-4.51) | 0.004 | 2.44 (1.78-3.10) |
Main indications of MRDT** | ||||
-Fever | 16 (88.89) | 18 (100) | 0.1 | 34 (94.44) |
-Headache | 14 (77.78) | 10 (55.56) | 0.1 | 24 (66.67) |
-Chills | 13 (72.22) | 7 (38.89) | 0.04 | 20 (55.56) |
No drug shop in village | 12 (66.67) | 17 (94.44) | 0.03 | 29 (80.56) |
Use village's kit** | 15 (66.67) | 15 (83.33) | 0.2 | 27 (75) |
Received ACT since (month)* | 5.94 (4.30-7.58) | 8.05 (7.09-9.01) | 0.02 | 7 (6.02-7.97) |
ACT shortage**** | 7 (38.89) | 10 (55.56) | 0.31 | 17 (47.22) |
Treatment for uncomplicated malaria μ | ||||
-Chloroquine | 14 (77.78) | 4 (22.22) | 0.004 | 18 (50.0) |
-Coartem® | 3 (16.67) | 7 (38.89) | 0.13 | 10 (27.78) |
-Paracetamol | 0 (0) | 6 (33.33) | 0.07 | 6 (16.67) |
-Quinine | 1 (5.56) | 1 (5.56) | 1 | 2 (5.56) |
Knows where to get ACT | 0 | 0 | 0 | |
Cannot describe severe malariaμμ | 11 (61.11) | 5(50) | 0.5 | 16 (44%) |
Ever diagnosed severe malaria | 7 (38.89) | 8 (44.44) | 0.7 | 15 (41.67) |
Treatment given for severe malaria (n = 15) | 3 (42.85) | 6 (75) | 9 (60) | |
- Referral | 2 (28.57) | 6 (75) | 0.07 | 8 (55.33) |
- Antimalarial | 3 (42.85) | 2 (25) | 0.4 | 5 (33.33) |
-Artesunate | 3 (42.86) | 0 | 0.03 | 3 (20) |
-Quinine μμμ | 0 (0) | 2 (25.5) | 0.3 | 1 (6.67) |
-Dextrose infusion alone | 1 (14.28) | 3 (37.5) | 0.3 | 4 (26.67) |